KING OF PRUSSIA, PA — Greenphire, a leading provider of clinical trial payment solutions, has announced the acquisition of Clincierge, a respected player in the realm of concierge travel and logistics support for clinical trial participants. This strategic move is expected to significantly transform the clinical trial support services landscape by combining top-tier patient care with advanced technology.
Based in Montgomery County, Pennsylvania, Greenphire is poised to enhance the participant journey and simplify the often complex processes for pharmaceutical companies and clinical research organizations around the globe. This acquisition underscores Greenphire’s commitment to delivering comprehensive solutions that cater to patients’ diverse needs, ensuring an efficient and seamless trial experience.
The integration of Greenphire and Clincierge’s expertise promises to stimulate innovation and growth within the clinical trial support industry. The key strategic rationales driving this acquisition include:
- Expanded Service Offerings: The merger of Clincierge’s specialized travel and logistics services with Greenphire’s existing suite of solutions will offer clients a comprehensive, end-to-end participant experience platform.
- Enhanced Participant Experience: The acquisition prioritizes patient-centric care by providing personalized, high-touch services aimed at improving patient engagement and satisfaction throughout the clinical trial process.
- Increased Trial Efficiency: The consolidation of both companies’ technologies will streamline trial processes, optimize resource allocation, and drive operational efficiencies, benefiting pharmaceutical clients, sites, and patients.
Greenphire CEO, Jim Murphy, commented on the acquisition, “This significant milestone for Greenphire reinforces our commitment to transforming the landscape of trial support services. By combining our technological prowess with Clincierge’s dedication to exceptional patient care, we are poised to redefine industry standards and drive meaningful advancements in clinical research.”
The acquisition comes after Greenphire’s 2023 Participant Convenience Market Research Survey revealed that “improving travel and logistical support” was the top priority for clinical operations among hundreds of sponsors and Clinical Research Organizations (CROs). This acquisition underscores Greenphire’s dedication to being a premier partner in advancing the efficiency, accessibility, and quality of clinical trials worldwide.
The integration of Clincierge’s services into Greenphire’s offerings will provide high-touch support to participants in rare and ultra-rare disease trials. The combination of participant support means complete coverage for every trial visit.
Both companies are enthusiastic about the opportunities this collaboration will bring and are committed to delivering enhanced value to pharmaceutical partners and patients alike.
Morris, Manning & Martin served as Greenphire’s legal counsel, while Stradley Ronon Stevens & Young acted as Clincierge’s legal counsel. Bourne Partners served as Clincierge’s exclusive financial advisor in the transaction.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.